MCM
PFE icon

MAI Capital Management’s Pfizer PFE Stock Holding History

MAI Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-316
Closed -$11K – 598
2019
Q3 		$11K Buy
+316
New +$11.5K ﹤0.01% 524

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

MAI Capital Management's PFE Position: Q2 2026 in Review

MAI Capital Management increased its Pfizer (PFE) stake by 46% in Q2 2026, buying an estimated $5.06M and bringing the position to 614,061 shares worth $14.8M. The position accounts for 0.06% of the portfolio, ranked #266.

MAI Capital Management first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $36.6M in Q4 2024. 2,841 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • MAI Capital Management held 614,061 shares of Pfizer worth $14.8M as of Q2 2026.
  • MAI Capital Management bought 193,369 Pfizer shares in Q2 2026, an estimated $5.06M.
  • Pfizer made up 0.06% of MAI Capital Management's portfolio in Q2 2026, its #266 holding.
  • MAI Capital Management first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
  • MAI Capital Management's Pfizer position peaked at $36.6M in Q4 2024.
  • 2,841 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on MAI Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.